Scala Biodesign utilizes a one-shot computational platform that combines evolutionary analysis and AI to enhance the stability, yield, and specificity of proteins for therapeutic and industrial applications. This technology addresses the limitations of natural proteins, which often lack the required resilience and efficiency for modern medical and manufacturing needs.
Funding
$5.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Naturally occurring proteins often lack the stability, specificity, and yield required for effective use in therapeutic and industrial applications. This limits their potential in pharmaceuticals, chemical manufacturing, and sustainable processes.
Solution
Scala Biodesign offers a computational protein design platform that leverages evolutionary analysis, atomistic calculations, and artificial intelligence to optimize protein properties. Their approach enhances protein stability, improves production yields, and increases specificity in a single design cycle. The platform's capabilities extend to a range of applications, including therapeutic enzymes, antibodies, vaccine immunogens, and industrial enzymes. Scala's technology reduces the need for extensive experimental iterations, accelerating protein engineering workflows and lowering development costs.
Target Audience
Scala Biodesign serves biotechnology and biopharmaceutical companies, as well as organizations in the chemical and sustainability industries, seeking to improve protein properties for various applications.
Features
- Computational platform combining evolutionary analysis, atomistic protein design, and AI
- One-shot design approach for rapid protein optimization
- Improves protein stability, thermostability, and resilience to solvents and pH
- Optimizes enzyme activity and specificity for industrial and therapeutic applications
- Humanizes and stabilizes therapeutic antibodies while maintaining target affinity
- Enhances protein production yields and expression in host organisms
- Applicable to enzymes, antibodies, vaccine immunogens, and membrane proteins